ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,784Medicare Part D Prescriptions Filled, Including Refills

Rank: 89 out of 6969

$794K Total Retail Price of All Prescriptions

Rank: 219 out of 6969

779 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 779 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

5% of this provider’s 15,314 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
METFORMIN HCL 844 629 1 7
OMEPRAZOLE 831 722 2 6
AMLODIPINE BESYLATE 682 621 3 4
LOVASTATIN 638 537 4 15
LISINOPRIL 541 431 5 2
SIMVASTATIN 539 423 6 1
GLYBURIDE-METFORMIN HCL 452 389 R 7 92
LEVOTHYROXINE SODIUM 399 340 8 5
LOSARTAN-HYDROCHLOROTHIAZIDE 392 350 9 53
FUROSEMIDE 358 310 10 10
HYDROCHLOROTHIAZIDE 341 267 11 8
TAMSULOSIN HCL 293 256 12 23
GLIPIZIDE 290 233 13 21
GLIMEPIRIDE 282 222 14 44
GABAPENTIN 259 194 15 17
CARVEDILOL 258 204 16 25
IBUPROFEN 242 185 17 29
ENALAPRIL MALEATE 237 190 18 56
ALENDRONATE SODIUM 232 221 19 14
HYDROCODONE-ACETAMINOPHEN 229 163 S3 20 3
TRAMADOL HCL 212 163 21 27
BENAZEPRIL HCL 210 170 22 18
MELOXICAM 200 176 23 36
ATENOLOL 196 160 24 9
NYSTATIN-TRIAMCINOLONE 192 166 25 278
LOSARTAN POTASSIUM 189 166 26 12
AZITHROMYCIN 187 152 27 42
METOPROLOL TARTRATE 186 141 28 13
FLUOXETINE HCL 169 132 29 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 164 130 30 28
ATORVASTATIN CALCIUM 163 134 31 11
CLOPIDOGREL 163 132 31 48
NAPROXEN 162 118 33 62
GLYBURIDE 154 123 R 34 54
FINASTERIDE 134 134 35 80
INSULIN SYRINGE 133 91 36 60
CIPROFLOXACIN HCL 133 109 36 64
ZOLPIDEM TARTRATE 129 91 38 16
LANTUS 128 87 39 50
METOPROLOL SUCCINATE 125 113 40 22
POTASSIUM CHLORIDE 114 101 41 30
DIOVAN 114 98 41 26
SPIRONOLACTONE 113 78 43 102
ONGLYZA 109 79 44 164
TRAZODONE HCL 107 66 45 47
PLAVIX 105 90 46 68
ACTOS 101 79 47 61
PANTOPRAZOLE SODIUM 100 90 48 31
HYDROXYZINE HCL 100 85 R 48 159
AMLODIPINE BESYLATE-BENAZEPRIL 98 92 50 91
FLUTICASONE PROPIONATE 97 80 51 24
CLONIDINE HCL 96 89 52 59
ADVAIR DISKUS 94 86 53 45
WARFARIN SODIUM 93 59 54 20
NIFEDIPINE ER 91 86 55 95
DIGOXIN 91 75 55 71
DIOVAN HCT 87 85 57 57
ALLOPURINOL 86 65 58 35
DICLOFENAC SODIUM 85 68 59 78
PAROXETINE HCL 85 69 59 65
KETOCONAZOLE 79 58 61 185
LEVEMIR FLEXPEN 76 66 62 253
CRESTOR 74 59 63 39
PRAVASTATIN SODIUM 73 59 64 19
GEMFIBROZIL 72 48 65 85
PROAIR HFA 71 63 66 33
LACTULOSE 71 49 66 131
NAMENDA 70 70 68 51
CELEBREX 69 55 69 67
AMOX TR-POTASSIUM CLAVULANATE 69 61 69 194
SERTRALINE HCL 69 48 69 38
FLUOCINONIDE 68 61 72 134
BENAZEPRIL-HYDROCHLOROTHIAZIDE 66 56 73 132
AMITRIPTYLINE HCL 65 46 R 74 87
DOXAZOSIN MESYLATE 63 63 75 74
BACLOFEN 62 43 76 86
JANUVIA 61 48 77 41
PROPRANOLOL HCL 59 56 78 153
METRONIDAZOLE 58 50 79 316
METOLAZONE 56 47 80 322
KLOR-CON 8 54 37 81 104
ISOSORBIDE MONONITRATE ER 52 48 82 81
LORATADINE 51 37 83 236
TERAZOSIN HCL 51 50 83 49
PREMARIN 50 45 R 85 156
NOVOFINE 32 50 44 85 522
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.